Tight junctions expression is affected by active, inactive, and derivatives of Akkermansia muciniphila

  • Farinaz Ghaderi Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
  • Zahra Hajebrahimi Air and Space Physiology Research Group, Aerospace Research Institute, Ministry of Science Research and Technology, Tehran, Iran
  • Abolfazl Fateh Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran,
  • Fattah Sotoodehnejadnematalahi Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
  • Sara Ahmadi Badi Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran
  • Somayeh Vaezijoze Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
  • Seyed Davar Siadat Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran
Keywords: Akkermansia muciniphila; Tight junctions; Zonula occludens-1; Occludin

Abstract

Background and Objectives: Tight junctions (TJs) in the gastrointestinal tract are comprised of various junctional proteins including Occludin and Zonula Occludens (ZO-1) that have a critical role in epithelial barrier function. Gut microbiota and their derived metabolites can maintain and regulate gut epithelial barrier integrity.

Materials and Methods: In the present study, the effects of active, heat-inactivated, cell-free supernatant, and outer mem- brane vesicles (OMVs) of Akkermansia muciniphila were evaluated on the expression of occludin and ZO-1 genes in Caco-2 cell line by quantitative real-time PCR.

Results: Data have shown that both forms of the active (metabolically active, growing, and dividing state), and heat inacti- vated (by exposure to 56°C for 20 minutes) forms of the bacteria and the cell-free supernatant could affect the expression of occludin and ZO-1 genes (P < 0.05). OMVs significantly increased the expression of the occludin gene but had no effects on the expression of ZO-1.

Conclusion: Akkermansia muciniphila and its derived metabolites might have the potential to be used in the pharmaceuti- cal and medicinal fields as probiotic, paraprobiotic and postbiotic agents to prevent metabolic and inflammatory diseases; Although, further research is needed to understand their interactions within the complex gut microbiome and to evaluate potential side effects or risks associated with their use.

Published
2025-12-10
Section
Articles